Skip to content
Saturday 22 August 2026London --:--Frankfurt --:--Zurich --:--
NewslettersSearchEN · DE · FR
MorningWire

European business, markets and politics

FTSE 100
10,816.56
+0.64%
DAX
26,136.56
+0.59%
CAC 40
8,484.43
+0.37%
STOXX 50
6,462.22
+0.63%
  • Europe
  • Markets
  • Business
  • Economy
  • Regulation
  • Politics
  • Opinion
More
GermanyFranceEU InstitutionsCompetitionPublic AffairsBankingTechnologyEnergy
  • Germany
  • France
  • Europe
  • Markets
  • Business
  • Economy
  • Regulation
  • Politics
  • Opinion
  • DE
Sunday 30 October 2022 3:15 pm  |  Updated:  Monday 31 October 2022 8:00 am

NHS Trusts back out of working with Bupa over unpaid medical bills

By: Millie Turner

Add as a preferred source on Google
Internet Companies Vie For Market Dominance
(Photo Illustration by Daniel Berehulak/Getty Images)

At least two NHS Trusts have reportedly backed out of working with medical insurer Bupa over claims of unpaid bills.

The Royal Surrey NHS Foundation Trust has called in lawyers and is threatening court action over £400,000 worth of private patient’s medical bills, which have gone unpaid, The Sunday Times first reported.

Oxford University Hospitals NHS Foundation Trust is also understood to have cut ties with the insurer.

Ross Dunworth, the Surrey trust’s finance director and deputy chief executive, told The Sunday Times: “Our negotiations with Bupa are ongoing and we have suspended our work with them in the interim — we hope to come to a resolution shortly.”

Meanwhile, the Oxford University trust is no longer accepting new Bupa patients.

The Financial Conduct Authority has also been in contact with Bupa, according to the report, after claims of massive premiums on customer’s once they become ill.

A Bupa spokesperson said: “The independent sector plays an important role in supporting the NHS, and Bupa has very good, long-standing relationships with dozens of NHS private practice units. 

“It is common practice for all health insurers to require invoicing within fixed time periods so that we have an up-to-date picture of customers’ claims and can let our customers know about their available allowances promptly, in their current policy year. 

“We offer a range of options and policies, and are always keen to talk to our customers to find the right plan to suit their budget and needs.”

Read more

NHS data counters claims that £330m Palantir deal has led to ‘no improvement’

Brit are seeking financial support from the ‘Bank of Mum and Dad’ to afford private healthcare.

Share this article

  • Facebook
  • X
  • LinkedIn
  • WhatsApp
  • Email

Similarly tagged content:

Sections

  • News

Categories

  • Business

Related Topics

  • NHS

Trending Articles

  • House prices in wealthy London boroughs fall by up to £300,000

  • As it happened: FTSE 100 rallies after JD Sports drags on blue chips; oil jumps again

  • Mike Ashley’s Frasers offers to pay personal shoppers in Harvey Nichols takeover

  • Ratcliffe’s Ineos saves Runcorn plant

  • Amazon says it buys books in bulk to ‘improve products’

More from Morning Wire

  • NHS data counters claims that £330m Palantir deal has led to ‘no improvement’

    Tech
    Brit are seeking financial support from the ‘Bank of Mum and Dad’ to afford private healthcare.
  • Leeds NHS Innovation to Accelerate Global Adoption of AI-enabled Pathology for Cancer Diagnostics Through Epredia Partnership

    Business Wire
  • Law firm at centre of BHP mammoth lawsuit sued by its own funder

    Lawsuit
    UK class actions surge, lawyers perceived as primary beneficiaries, public awareness highest since 2020, report finds
  • AIM-Listed Pulsar Group hit with High Court petition by HMRC

    Media
    HMRC overcharged pensioners thousands
  • Aviva profits jump following Direct Line acquisition

    Insurance
    Aviva's deal to buy Direct Line was agreed in March
  • Champions Cup rugby team hacked in ransom attack with player data at risk

    Sport Business
    Rugby player in a pink uniform running with the ball, pursued by an opponent in a black jersey.
  • Nanochon Receives Regulatory Approval from Panamá’s Ministry of Health to Initiate First-in-Human Clinical Study of Chondrograft™

    Business Wire
  • Azalea Vision Appoints Co-Founder Andrés Vasquez Quintero as Chief Executive Officer to Lead Next Phase of Clinical Development

    Business Wire
MorningWire

Independent European business, markets and political news for decision-makers.

Morning Briefing

Europe

  • Germany
  • France
  • EU Institutions
  • Europe

Business

  • Markets
  • Business
  • Economy
  • Regulation
  • Competition
  • Public Affairs

Editorial

  • Opinion
  • Editorial Policy
  • Corrections
  • Contact

Company

  • About Morning Wire
  • Privacy Policy
  • Terms of Use
  • Cookie Policy
© 2026 Morning Wire Ltd · Published by Morning Wire Media, Bahnhofstrasse 65, 8001 Zürich, Switzerland
Privacy · Terms · Cookies · Facebook